MRSH vs XP: fair value comparison
Marsh & McLennan Companies, Inc. and XP Inc. · Updated 2026-10-19
MRSH has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. XP reports in BRL, so no same-currency fair-value verdict is published for it. Within Financial Services, MRSH currently ranks higher by quality score.
| MRSH | XP | |
|---|---|---|
| Verdict | No estimate yet | Awaiting full valuation |
| Last price | $188.35 | $21.17 |
| 12-month range | $157.32–$197.59 | $14.94–$32.60 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #141 of 207 Financial Services | #143 of 207 Financial Services |
| Quality grade | D | D |
| Leverage | High | High |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | — | Uptrend |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: MRSH fair value analysis · XP fair value analysis